Almost half of people do not think 10-year plan will boost GP access
However, there is huge support for some of the ideas included in the blueprint, with the overwhelming majority backing the creation of neighbourhood health centres, the expansion of the NHS app and more mental health support in schools and colleges.
The 10-year health plan was unveiled by Prime Minister Sir Keir Starmer earlier this month, and set out a series of shifts to bring care much closer to people's homes, reducing the reliance on hospitals and A&E.
Key reforms include an enhanced NHS app, giving patients more control over their care, new neighbourhood health centres open six days a week and at least 12 hours a day, and new laws on food and alcohol to prevent ill health.
A survey of 1,023 adults in Britain, conducted by Ipsos for the PA news agency, asked people how they think the plan will impact access to healthcare, such as getting a GP appointment, A&E waiting times and waiting times for routine hospital treatment.
Some 35% said the plan will have no impact on getting a GP appointment, while 14% believe it will make things harder.
This compares with the 29% of people who said they think it will make getting an appointment easier.
More than a third (37%) said it will make no difference to waiting times in emergency departments, while almost one in 10 (9%), said they believe it could worsen waiting times, compared with 30% who said it will improve them.
Meanwhile, 31% said the plan will have no impact on waiting times for hospital treatment, 11% believe the plan will worsen waiting times and 34% said they think the measures will help.
However, a number of proposals outlined in the plan were strongly backed by the public.
Some 84% said they supported the creation of a single patient record, while 78% backed the creation of neighbourhood health centres, 73% support the expansion of the NHS app and 72% are in favour of more mental health support in schools and colleges.
However, more than a quarter (27%) of people do not support making hospitals fully AI enabled, compared with 44% who would back the move.
Almost one in five (18%) said they would not support so-called 'patient power payments', which would allow patients to hold back some of the payment for their care if they are not satisfied, while 42% would support the measure.
Some proposals aimed at helping people to lead healthier lives were also strongly supported.
A ban on the sale of high-caffeine energy drinks was backed by 78% of people, while 69% back plans to restrict junk food advertising.
However, almost one in five (18%) tended to disagree with measures that could see alcoholic drinks labelled with nutritional information, although 57% backed the move.
One in four people think the measures included in the plan will make no difference to patients, the poll found.
Almost one in 10 (9%) said they think the changes will make things worse, while 35% believe it will improve the health service.
A similar proportion, 23%, said the 10-year health plan will make no difference to NHS staff, while 13% said it could make things worse and 33% believe it will have a positive effect.
A Department of Health and Social Care spokesperson said: 'We're getting on with the job of delivering for patients, with NHS waiting lists falling by 260,000 since July 2024, delivering more than 4.6 million additional appointments since the general election and recruiting over 1,900 extra GPs to fix the front door of the NHS.
'Backed by an additional £29 billion, our 10-year health plan will seize the opportunities provided by new technology, medicines and innovation to deliver better care for all patients, no matter where they live or how much they earn, and better value for taxpayers.
'It is no surprise the plan is popular with patients, it was the result of the biggest conversation with staff, patients and the public since the formation of the NHS, with more than a quarter of a million contributions.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
4 minutes ago
- The Independent
Failings identified in care of boy who died after he was sent home from A&E
The mother of a five-year-old boy who died after he was sent home from A&E has said she hears her son every night saying 'Mummy, I can't breathe', as a report concluded she was not listened to by health professionals. Yusuf Mahmud Nazir died at Sheffield Children's Hospital on November 23 2022, eight days after he was seen at Rotherham Hospital and sent home with antibiotics. A fresh report into Yusuf's care was published on Thursday with a range of recommendations for the NHS, but his family said there are still many unanswered questions and have demanded an inquest into his death. The report said in its conclusions: 'Our primary finding is that the parental concerns, particularly the mother's instinct that her child was unwell, were repeatedly not addressed across services. 'A reliance on clinical metrics over caregiver insight caused distress for the family. 'This led to a lack of shared decision-making and there was limited evidence of collaborative discussions with Yusuf's family around clinical decisions, leading to a sense of exclusion and reduced trust in care plans.' Speaking at a press conference in Rotherham, Yusuf's mother, Soniya Ahmed, said: 'For the medical staff there are lessons to be learnt from this tragedy, but for us, our life, Yusuf has been taken away from us in the most horrific way. 'Every night when I close my eyes I hear Yusuf's helpless voice in my ears saying, 'Mummy, I can't breathe, I can't breathe, I really can't'. 'And the image of him being handed over to me after his life ended, as though someone has torn my heart out and placed it in my hands.' Ms Ahmed choked back tears as she said: 'Along with these failings, there is still uncertainty on his cause of death. 'Yusuf deserved better. Every child does. I will never stop speaking his name. I will never stop fighting for him. I fight for every child failed by the NHS. 'We demand accountability, we demand change. 'We want to know how our son has died and who is responsible, and the only way we will get these answers is with an inquest. The family demand an inquest.' Yusuf's uncle Zaheer Ahmed has always said they were told 'there are no beds and not enough doctors' in the emergency department, and that Yusuf should have been admitted and given intravenous antibiotics in Rotherham. Yusuf, who had asthma, was taken to a GP with a sore throat and feeling unwell on November 15. He was prescribed antibiotics by an advanced nurse practitioner. Later that evening, his parents took him to Rotherham Hospital urgent and emergency care centre (UECC) where he was seen in the early hours of the morning after a six-hour wait. He was discharged with a diagnosis of severe tonsillitis and an extended prescription of antibiotics. Two days later Yusuf was given further antibiotics by his GP for a possible chest infection, but his family became so concerned they called an ambulance and insisted the paramedics take him to Sheffield Children's Hospital rather than Rotherham. Yusuf was admitted to the intensive care unit on November 21 but developed multi-organ failure and suffered several cardiac arrests which he did not survive. A report into his case in October 2023, produced by independent consultants and published by NHS South Yorkshire, found his care was appropriate and 'an admission was not clinically required', but this was rejected by his family. The fresh report by Peter Carter, former general secretary of the Royal College of Nursing, said it was agreed that Yusuf had pneumonia and sepsis, which led to respiratory failure and his death, but 'no causative agent' could be found. It said: 'It is impossible to make a statement on whether (intravenous) antibiotics or earlier detection would have prevented Yusuf's death. 'We understand that this is not the information that the family obtained initially and appreciate how this difference of professional opinion has led to confusion and emotional distress for the family.' The report said Yusuf had 23 separate healthcare contacts across four organisations 'with no single, co-ordinated record or oversight, contributing to fragmented and disjointed care'. The family said they were most surprised by the report's findings in relation to Sheffield Children's Hospital, including that it used an outdated cannula method which deprived Yusuf of drugs he needed. But the report also said it asked experts to assess whether there was 'any clinical evidence to suggest that Yusuf's earlier admission to (Rotherham Hospital) for IV antibiotics, would have possibly prevented Yusuf's death', and the reply was: 'I do not believe it would have done.' Mr Ahmed said on Thursday: 'Despite the report's findings, we still believe that if Yusuf was admitted to Rotherham General Hospital and has received IV antibiotics, that he would still be here today.' He added: 'We miss Yusuf every single day'. Health Secretary Wes Streeting said: 'There are no excuses for the tragic failings in the lead-up to Yusuf's death and I know first-hand how hard it has been for his family to live without the answers they deserve. 'This independent report reveals their concerns were repeatedly not addressed across NHS services. 'It is now the responsibility of the NHS to implement the recommendations in this report so that the family can at least take small comfort in knowing that because of Yusuf, and thanks to Yusuf, children will be safer and better cared for in the future, but I know that really is of no consolation for a loving family living with the unimaginable pain of losing a lovely little boy in these awful circumstances.' Professor Aidan Fowler, national director of patient safety in England, said: 'Our thoughts and sincere condolences remain with the family of Yusuf Nazir who have suffered an unbearable loss. 'We accept the report's recommendations and acknowledge the issues this independent investigation has uncovered, particularly the failure to listen to and act on the concerns of Yusuf's family by multiple NHS services, which is unacceptable.' Dr Jeff Perring, executive medical director at Sheffield Children's NHS Foundation Trust, said: 'The report identifies important areas for learning and improvement, not only for us at Sheffield Children's but also across the wider healthcare system. 'We are dedicated to delivering the improvements outlined in the report's recommendations.' Dr Jo Beahan, medical director at Rotherham NHS Foundation Trust, said: 'Our deepest sympathies remain with Yusuf's family following such a sad loss of a loved family member. We fully co-operated with this investigation into Yusuf's care. 'We have taken steps to address the recommendation and also the concerns raised by Yusuf's family. Our thoughts continue to be with Yusuf's family.'
BBC News
4 minutes ago
- BBC News
Surrey and Sussex NHS Trust receives £12.7m for two new theatres
The Surrey and Sussex NHS Trust has received a funding boost of £12.7m, which they say will allow them to build two new theatres on the site of the East Surrey trust said the funding had arrived at a "crucial time" as current operating theatres on the site were at maximum capacity, as well as growing waiting lists and increasing emergency demand.A spokesperson for the trust said the funding and theatres would mean the hospital could "continue to deliver the highest standards of patient care".The work is due to start on the site in Redhill later in 2025. The trust's chief executive, Angela Stevenson, said: "This new funding from NHS England will be truly transformative for the future of our hospital and our patients. "In the midst of some tough financial decisions, this is a really positive step-change in how we deliver for our patients."
Daily Mail
5 minutes ago
- Daily Mail
Top GP urges men to know the signs of penis cancer... as it becomes a bigger killer than testicular cancer
A leading GP has warned men to watch out for the silent signs of a deadly cancer that kills hundreds each year, overtaking testicular cancer deaths. Penile cancer is notoriously hard to spot because symptoms can easily be mistaken for less serious problems, which men are often too embarrassed to talk about. As a result, late diagnosis is becoming increasingly common, with many men ignoring early warning signs—which could result in amputation. Of men diagnosed with penile cancer early, more than 90 per cent go on to survive at least five years after diagnosis. However, the outlook for men with the most advanced cancer where it has spread to other parts of the body is bleak: no men in this group are expected to survive for five years after their diagnosis. B NHS GP Dr Mark Porter says men could help reduce their risk of a late-stage diagnosis by watching out for the little known signs of the deadly disease which may not only save their lives, but their penises too. According to Cancer Research UK, 63 per cent of penile cancer cases in the UK are preventable. Writing for The Times he said whilst cancer can develop anywhere on the penis, most penile cancers affect the foreskin or the head (glans) of the penis. Common early symptoms include discolouration—which is often red or bluish-brown—a persistent rash or sore that lasts longer than a month, and an obvious lump or growth either on the penis or surrounding groin area. Other red-flag warning signs include bleeding, abnormal discharge and phimosis—where it becomes difficult to retract the foreskin. However, he added these symptoms are not always a cause for serious concern and are usually the result of an infection like thrush or inflammatory conditions. It is also not uncommon for men to experience bleeding after trauma to the sensitive area which can tear the frenulum, the band of tissue that connects the foreskin to the head of the penis. This can happen after intercourse, he added. Even so, Dr Porter urged men not to dismiss any abnormal changes to the area, however slight, and to contact their GP if they are concerned. 'There is a good chance the result won't be as bad as you feared—but that doesn't mean it's okay to put off that appointment,' he said. Whilst penile cancer is rare and typically affects middle-aged men, it can develop much sooner, making early diagnosis crucial. 'The other major advantage of early diagnosis is that often it means treatment is less invasive,' the GP explained. According to the NHS, treatment for early cancer is usually non-surgical, including chemotherapy creams such as 5 fluorouracil and laser therapy through which suspicious lesions are 'burnt off'. However, if the cancer is found later, perhaps as a result of patients putting off seeking help, treatment is a lot more aggressive. This can include removing the top layer of skin from the head of the penis, cutting out lymph nodes—which help the body to fight off infection—and even amputation. A full amputation, known as a penectomy, also involves having to have a new outlet for the bladder made between the anus and scrotum. But, the NHS warns, any surgery is likely to affect how a patient's penis looks. Chemotherapy, radiotherapy and immunotherapy can all also be used to help shrink tumours and reduce the risk of the cancer spreading further. Reconstructive surgery is an option for men who have had to have their penis removed, using skin and muscles from other parts of the body to make a fully functioning penis. Whilst any man can get penile cancer certain factors can increase an individual man's risk of developing the disease. According to the NHS around half of all penile cancers are caused by certain types of HPV which affect the genital area. The virus—medically known as human papillomavirus—can be spread via skin-to-skin contact of the genital area, vaginal, anal or oral sex and sharing sex toys. As such, according to Cancer Research UK, 63 per cent of penile cancer cases are preventable. Smoking also increases the risk of developing the disease and those who are immunocompromised due to conditions like HIV are also more likely to get penile cancer. Dr Porter added: 'Circumcision as a child or teenager offers protection against the disease as it reduced exposure to secretions known as smegma produced by the foreskin.' A six-year study was launched back in 2021 to ascertain how successful a new form of immunotherapy—called cemiplmab—is at treating penile cancer that has spread. The Epic study, led by Professor Amit Bahl a urology professor at the University of Bristol, is still ongoing but if initial findings can be upheld experts believe it could help prolong the lives of men with advanced penile cancer. Around one in 400 men in the UK are diagnosed with penile cancer each year, with the disease killing twice as many men as testicular cancer.
